_michael_scholl Profile Banner
Michael Schöll Profile
Michael Schöll

@_michael_scholl

Followers
2K
Following
3K
Media
50
Statuses
613

Professor at the Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, and Principal Research Fellow at the UCL DRC

Gothenburg, Sweden
Joined June 2017
Don't wanna be here? Send us removal request.
@_michael_scholl
Michael Schöll
4 years
So excited and honoured to be elected to the Young Academy of Sweden! I am very grateful for this opportunity to actively impact research politics and work conditions for young research leaders
@Ungaakademin
Sveriges unga akademi
4 years
Fantastiska forskare från ett brett spektrum av discipliner: 8 nya ledamöter välkomnas till Sveriges unga akademi: https://t.co/GGHmMjnwOy @umeauniversitet @lunduniversity @uppsalauni @SCAS_Uppsala @goteborgsuni @karolinskainst
22
1
116
@JosephTherr
Joseph Therriault
3 months
I’m proud to share our systematic review & meta-analysis of plasma p-tau diagnostic accuracy studies :) https://t.co/zXOs1Yu6uF Some highlights:
1
20
43
@alzforum
Alzforum
4 months
Largest-ever tau-PET studies confirm ties between tangles and cognitive decline. ApoE4 carriers and women get tangles earliest. @_michael_scholl @AlexisMoscoso9 @amsterdamumc
0
9
27
@NicholasAshton
Nicholas Ashton
5 months
NPTX2 is emerging as a key neurodegeneration biomarker, but measurement tools are limited. We developed a low-volume, automated Simoa assay for its quantification in CSF #biomarkers #neurodegeneration https://t.co/tjukHVl7qd
1
9
41
@_michael_scholl
Michael Schöll
5 months
Our most important paper, out now! A massive international collaboration, led by @AlexisMoscoso9, featuring over 6500 visually assessed tau PET scans covering the #Alzheimers spectrum! Thank you very much to the numerous contributors and collaborators who made this gem possible.
@JAMA_current
JAMA
5 months
Tau PET positivity is detectable in a small but nonnegligible proportion of individuals in the preclinical stages of #Alzheimer disease, with increasing frequency in symptomatic stages of the disease. https://t.co/TK1U5vHw9j
2
13
52
@JAMA_current
JAMA
5 months
Tau PET positivity is detectable in a small but nonnegligible proportion of individuals in the preclinical stages of #Alzheimer disease, with increasing frequency in symptomatic stages of the disease. https://t.co/TK1U5vHw9j
0
4
17
@MolNeuro
Molecular Neurodegeneration
6 months
'Cautions on utilizing plasma GFAP level as a #biomarker for reactive #astrocytes in #neurodegenerative diseases' Wongu Youn, Mijin Yun @CJustinLee1 Michael Schöll @_michael_scholl @uniofgothenburg https://t.co/tLAJbqy5d4
Tweet card summary image
molecularneurodegeneration.biomedcentral.com
0
5
19
@EmmaCoomans
Emma Coomans
6 months
So excited and honored to be invited to present the opening plenary at #AIC2025 this year in Toronto! 🧠 🙏 I would be very grateful if you could help me gather the most inspiring papers (including your own!) of the past year by completing this survey:
@NeuroimagingPIA
Neuroimaging PIA
6 months
🚨Calling all neuroimagers! Help @EmmaCoomans shape the opening plenary at #AIC2025 (Toronto, July 26th) "Accomplishments of the Past Year" and share the most impactful neuroimaging research from the past year via this brief survey (~5min) by May 30th. https://t.co/5KpVMpzC7a
1
12
32
@neurochem4
Jörg Hanrieder
7 months
Happy to share our latest work published today in @NatureComms We leverage #ai enhanced microscopy guided #maldi @imaging_ms to delineate #amyloid plaque polymorphism in #Alzheimers Fantastic collaboration with @_michael_scholl https://t.co/wRuCWQ8QFi @SahlgrenskaAcad @UCLIoN
0
4
11
@MasudHusain
Masud Husain
8 months
Why academia is sleepwalking into self-destruction. My editorial @Brain1878 If you agree with the sentiments please RT. It's important for all our sakes to stop the madness https://t.co/5S5rL8Yda1
33
196
447
@davecash75
Dave Cash
9 months
Congratulations to @WillCoath on passing his PhD viva exploring amyloid and tau PET in the Insight 1946 birth cohort! Many thanks to examiners Prof @Hammers_Alexand and @PareshMalhotra and fellow supervisors @_michael_scholl and @jmschott
1
5
21
@nfranzme
Nico Franzmeier
10 months
Incredibly happy and proud to share our newest work in @ScienceTM showing that Aβ promotes neuronal hyperconnectivity, thereby driving tau spread across connected brain regions. Many thanks to to first authors @SebRoemer and Fabian Wagner! https://t.co/irKeFkbsz6 Thread below
science.org
Aβ induces neuronal hyperconnectivity, which promotes tau spreading from temporal lobe epicenters to connected brain regions in Alzheimer’s disease.
2
24
80
@_michael_scholl
Michael Schöll
10 months
Always my favourite post at the beginning of the year: Registration for our course “Biomarkers for neurodegenerative diseases” is now open! This year’s edition takes place at @UCLIoN in central London on May 12-16. https://t.co/ix28Tw1VHQ
1
19
59
@_michael_scholl
Michael Schöll
10 months
Happy to share this narrative review paper on the clinical use of blood-based biomarkers for #Alzheimer’s disease, hopefully this can serve as a resource to anyone seeking advice on implementation #endalz https://t.co/h0wV7fincX
1
8
37
@UCLBrainScience
UCL Brain Sciences
11 months
We're delighted that 22 of our academics have been identified in Clarivate’s annual ‘Highly Cited Researchers List’ 2024, recognising authors of the most influential research papers around the world. 🔗 https://t.co/YCVfq0ij91
0
5
9
@_michael_scholl
Michael Schöll
1 year
Third time’s a charm! 🎈 Very honoured to be ranked among the world’s most influential researchers according to Clarivate Web of Science three years in a row now! Praise belongs to my team, our collaborators and our study participants! https://t.co/tgY4qD3vSg
Tweet card summary image
clarivate.com
The Highly Cited Researchers 2024 list identifies and celebrates individuals who have demonstrated significant and broad influence in their fields of research. Through rigorous selection criteria and...
3
0
28
@Laura_Sofia_S
Laura Stankeviciute, PhD
1 year
Hej hej!🇸🇪 Happy to share that I’ve started a new postdoc with @_michael_scholl on the #REAL-AD study! Grateful for joining his incredible team together with @EllenSingletonn and contributing to this purposeful research 🧠✨ #endalz
1
2
36
@_michael_scholl
Michael Schöll
1 year
Please join us in Gothenburg on January 30 for a symposium on recent advances in the cognitive assessment of neurodegenerative diseases! We are excited to host a truly excellent panel of lecturers! Please register free of charge by email to ann-sophie.hilkert@gu.se #ENDALZ
3
6
33
@zimmerneurolab
Zimmer Lab
1 year
🚨 Check out our recent study on @GreenJournal 🧠 @andreibieger & colleagues developed an algorithm to compare the outcomes of different Alzheimer’s disease diagnostic criteria in the same group of individuals 🪢👇
neurology.org
Background and ObjectivesUpdates in Alzheimer disease (AD) diagnostic guidelines by the National Institute on Aging-Alzheimer's Association (NIA-AA) and the International Working Group (IWG) over the...
1
11
20